Home       Privacy       Archive       Realtime Report



Stock Trading History of Abel Douglas

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Abel Douglas since year 2005. The trader's CIK number is 1324106. At the time of this reporting, Abel Douglas is the President and CEO of Manhattan Pharmaceuticals Inc (stock ticker symbol MHTT).

Stock purchases, sales, and option exercises reported by Abel Douglas since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2006-07-10 MHA Manhattan Pharmaceuticals Inc Purchase 5,000 .75 3,750
2005-11-18 MHA Manhattan Pharmaceuticals Inc Purchase 5,000 1.28 6,400
2005-10-21 MHTT Manhattan Pharmaceuticals Inc Purchase 5,000 1.31 6,550
2005-10-20 MHTT Manhattan Pharmaceuticals Inc Purchase 5,000 1.29 6,465
2005-04-26 MHTT Manhattan Pharmaceuticals Inc Purchase 2,500 1.42 3,550
2005-04-25 MHTT Manhattan Pharmaceuticals Inc Purchase 5,000 1.50 7,500
2005-04-21 MHTT Manhattan Pharmaceuticals Inc Purchase 2,500 1.53 3,825

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Abel Douglas (President and CEO of Manhattan Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.